par Panaccione, R;Fedorak, R;Aumais, G;Bernard, Edmond-Jean;Bernstein, C N;Bitton, A;Croitoru, K;Dieleman, L A;Enns, Richard H.;Feagan, B G;Franchimont, Denis 
;Greenberg, G R;Griffiths, Anne-Marie;Marshall, John K;Pare, P;Patel, S;Penner, R;Render, C;Seidman, E;Steinhart, A H
Référence Canadian journal of gastroenterology, 22, 3, page (261-272)
Publication Publié, 2008-03
;Greenberg, G R;Griffiths, Anne-Marie;Marshall, John K;Pare, P;Patel, S;Penner, R;Render, C;Seidman, E;Steinhart, A HRéférence Canadian journal of gastroenterology, 22, 3, page (261-272)
Publication Publié, 2008-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Panaccione, R; Fedorak, R; Aumais, G; Bernard, Edmond-Jean; Bernstein, C N; Bitton, A; Croitoru, K; Dieleman, L A; Enns, Richard H.; Feagan, B G; Franchimont, Denis; Greenberg, G R; Griffiths, Anne-Marie; Marshall, John K; Pare, P; Patel, S; Penner, R; Render, C; Seidman, E; Steinhart, A H |
| Informations sur la publication: | Canadian journal of gastroenterology, 22, 3, page (261-272) |
| Statut de publication: | Publié, 2008-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Anti-Inflammatory Agents -- administration & dosage |
| Anti-Inflammatory Agents -- contraindications | |
| Anti-Inflammatory Agents -- therapeutic use | |
| Antibodies, Monoclonal -- administration & dosage | |
| Antibodies, Monoclonal -- contraindications | |
| Antibodies, Monoclonal -- therapeutic use | |
| Colitis, Ulcerative -- drug therapy | |
| Gastrointestinal Agents -- administration & dosage | |
| Gastrointestinal Agents -- contraindications | |
| Gastrointestinal Agents -- therapeutic use | |
| Humans | |
| Infusions, Intravenous | |
| Randomized Controlled Trials as Topic | |
| Remission Induction | |
| Risk Assessment | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0835-7900 |
| info:pmid/18354755 | |
| PMC2662201 |
